Overall, the data indicate that IFN-β administration could decrease symptoms severity, ICU admission, and - in some studies - overall hospital stay; however, effects on mortality reduction did not reach statistical significance in recent pooled analysis ( 83 , 84 ).
← all excerpts
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review.
1
—
—